MTCM
KDNY

Mint Tower Capital Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Mint Tower Capital Management’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,734
Closed -$374K – 275
2023
Q2 		$374K Buy
+9,734
New +$374K 0.04% 98